Biogen discontinues Alzheimer's drug Aduhelm
Biogen, maker of the Alzheimer's medicine Aduhelm, announced Wednesday that it would "discontinue the development and commercialization" of the controversial drug.
Source: yahoo.com
Page 3 - Aduhelm News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aduhelm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aduhelm Today - Breaking & Trending Today
Mass.-based Biogen will shut down its controversial Alzheimer's drug
Biogen will stop developing its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster before stumbling soon after its launch a couple years ago.
Source: wcvb.com
Biogen abandons controversial Alzheimer's drug Aduhelm
Biogen discontinues Alzheimer's drug Aduhelm, which has a lack of coverage amid efficacy concerns, after weighing its finances. It is redirecting efforts to Leqembi, approved by FDA in 2023.
Source: beckershospitalreview.com
An Ultrasound Experiment Tackles a Giant Problem in Brain Medicine
The effects of drugs that treat Alzheimer’s, cancer and other illnesses are often limited by the blood-brain barrier. A small study suggests a way forward.
Source: nytimes.com
Medicare Lifts Its Coverage Limit On Alzheimer's Disease PET Scans
Easing access to Alzheimer's diagnostic tests is critical in light of recent approvals of drugs to reduce amyloid plaque. But questions remain regarding equitable access.
Source: forbes.com